Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 64

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 4
Chunk 64
---
 – Lavie Bio offers tailored                                                   
                solutions to potential partners. In this model, Lavie Bio’s partner produces and commercializes the products being developed. Lavie         
               Bio’s revenues in such engagements may include research and development payments, payments upon achievement of development milestones        
       and royalties. The scope of collaboration may differ. The typical model is that Lavie Bio develops a product until it is ready for commercialization,
             and the partner is responsible for the production and commercialization of the product. This model was used in the agreement with Corteva      
                 that was signed in July 2023, where Corteva received a license to Lavie Bio’s bio-fungicide product targeting fruit rots in grapes         
               and other high value crops. Another model is when the collaboration starts in a much earlier development phase, where Lavie Bio would        
            typically commence with candidate strains discovery and development, followed by co-development with the partner towards commercialization.     
                                       Lavie Bio’s collaboration with ICL is an example of this broader collaboration model.                                
------------------------------------------------------------------------------------------------------------------------------------------------------------
Product Development Programs
 
Scientific Approach
 
Lavie Bio’s approach is focused on ‘Biology Driven Design’ for the discovery, optimization and commercialization of efficacious, consistent and commercially viable microbial-based ag-biologicals. Lavie Bio’s approach is based on converging the plant, microbial and environmental factors to decode their complex interactions in order to enable the amplification of the positive, elimination of the negative and retrieval of lost interactions within the biological system.
 
Lavie Bio’s Biology Driven Design, or BDD, facilitates and accelerates the design and development of microbiome-based products through the decoding of complex microbiome-host interactions and the identification of the key genetic elements (functions) governing these interactions. This decoding is powered by big data and artificial intelligence and provides the basis for products design. The enabling technologies for the establishment of the BDD platform are Evogene’s MicroBoost AI tech engine and Taxon Biosciences’ Taxonia platform, which harness genomics and informatics to develop transformative applications to agriculture, acquired as part of the Taxon Biosciences acquisition.
  
                                                                                              ________________________                                                                                              
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
1 https://www.marketsandmarkets.com/Market-Reports/agricultural-biological-market-100393324.html?gad_source=1&amp;gclid=Cj0KCQiA1p28BhCBARIsADP9HrMIMUFTDJ05rb-M